Cargando…

Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model

BACKGROUND: The anti-tumor efficacy of human immune effector cells, such as cytolytic T lymphocytes (CTLs), has been difficult to study in lung cancer patients in the clinical setting. Improved experimental models for the study of lung tumor-immune cell interaction as well as for evaluating the effi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oflazoglu, Ezogelin, Elliott, Mark, Takita, Hiroshi, Ferrone, Soldano, Henderson, Robert A, Repasky, Elizabeth A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1933531/ https://www.ncbi.nlm.nih.gov/pubmed/17592641 http://dx.doi.org/10.1186/1479-5876-5-29

Ejemplares similares

The anti-tumor effect of Apo2L/TRAIL on patient pancreatic adenocarcinomas grown as xenografts in SCID mice
por: Hylander, Bonnie L, et al.
Publicado: (2005)

Strong priming of T cells adoptively transferred into scid mice
Publicado: (1991)

Origin of the vasculature supporting growth of primary patient tumor xenografts
por: Hylander, Bonnie L, et al.
Publicado: (2013)

D Quantification of Tumor Vasculature in Lymphoma Xenografts in NOD/SCID Mice Allows to Detect Differences among Vascular-Targeted Therapies
por: Righi, Marco, et al.
Publicado: (2013)

Antibody Directed against Human YKL-40 Increases Tumor Volume in a Human Melanoma Xenograft Model in Scid Mice
por: Salamon, Johannes, et al.
Publicado: (2014)

Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death
por: Smith, Andressa A, et al.
Publicado: (2013)

Lymphocytes in tumor-draining lymph nodes co-cultured with autologous tumor cells for adoptive cell therapy
por: Okamura, Kazumi, et al.
Publicado: (2022)

Combination of the anti-CD30-auristatin-E antibody-drug conjugate (SGN-35) with chemotherapy improves antitumour activity in Hodgkin lymphoma
por: Oflazoglu, Ezogelin, et al.
Publicado: (2008)

Correction: D Quantification of Tumor Vasculature in Lymphoma Xenografts in NOD/SCID Mice Allows to Detect Differences among Vascular-Targeted Therapies
por: Righi, Marco, et al.
Publicado: (2013)

Rapid Growth and Spontaneous Metastasis of Human Germinal Tumors Ectopically Transplanted into Scid (Severe Combined Immunodeficiency) and Scid‐nude(streaker) Mice
por: Nomura, Taisei, et al.
Publicado: (1991)

Human Tumor–infiltrating Lymphocytes Transfected with Tumor Necrosis Factor Gene Could Augment Cytotoxicity to Autologous Tumor Cells
por: Itoh, Yoshinori, et al.
Publicado: (1991)

Comparison between NOD/SCID mice and BALB/c mice for patient-derived tumor xenografts model of non-small-cell lung cancer
por: Wu, Jianbin, et al.
Publicado: (2018)

Adoptive transfer of tumor infiltrating lymphocytes for metastatic cervical cancer
por: Hinrichs, Christian S, et al.
Publicado: (2013)

Improving the outcome of adoptive cell transfer by targeting tumor escape
por: Kaluza, Karen M., et al.
Publicado: (2013)

Induction of Specific Cytotoxic T Lymphocytes against Autologous Brain Tumor by Crossreactive Allo‐tumor Cell Stimulation
por: Saitoh, Seiji, et al.
Publicado: (1997)

Cytotoxic Activity of CD4(+) T Cells against Autologous Tumor Cells
por: Konomi, Yasushi, et al.
Publicado: (1995)

Paving the Way to Solid Tumors: Challenges and Strategies for Adoptively Transferred Transgenic T Cells in the Tumor Microenvironment
por: Füchsl, Franziska, et al.
Publicado: (2022)

EGFR-mediated tumor immunoescape: The imbalance between phosphorylated STAT1 and phosphorylated STAT3
por: Concha-Benavente, Fernando, et al.
Publicado: (2013)

Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor
Publicado: (1988)

Durable complete response in a patient with metastatic melanoma following adoptive transfer of autologous T cells recognizing 10 mutated tumor antigens
por: Prickett, Todd D, et al.
Publicado: (2015)

The role of tumor expression of CD200 in tumor formation, metastasis and susceptibility to T lymphocyte adoptive transfer therapy
por: Talebian, Fatemeh, et al.
Publicado: (2012)

Cancer Stem Cells Are Possible Key Players in Regulating Anti-Tumor Immune Responses: The Role of Immunomodulating Molecules and MicroRNAs
por: Tomei, Sara, et al.
Publicado: (2021)

Proscillaridin A is cytotoxic for glioblastoma cell lines and controls tumor xenograft growth in vivo
por: Denicolaï, Emilie, et al.
Publicado: (2014)

In vitro Generation of Cytotoxic T Cells With Potential for Adoptive Tumor Immunotherapy of Multiple Myeloma
por: Khalaf, Wafaa S., et al.
Publicado: (2019)

Human Ovarian Cancer Tumor Formation in Severe Combined Immunodeficient (SCID) Pigs
por: Boettcher, Adeline N., et al.
Publicado: (2019)

Interleukin‐12 Augments the Generation of Autologous Tumor‐reactive CD8(+) Cytotoxic T Lymphocytes from Tumor‐infiltrating Lymphocytes
por: Kuge, Soichi, et al.
Publicado: (1995)

Applications of patient-derived tumor xenograft models and tumor organoids
por: Yoshida, Go J.
Publicado: (2020)

Tumor vessel-injuring ability improves antitumor effect of cytotoxic T lymphocytes in adoptive immunotherapy
por: Kanagawa, N, et al.
Publicado: (2013)

Autologous whole-tumor antigen vaccination in combination with adoptive T cell therapy for patients with recurrent ovarian cancer
por: Kandalaft, Lana E, et al.
Publicado: (2013)

Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma
Publicado: (1988)

Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option
por: Rohaan, Maartje W., et al.
Publicado: (2018)

Bispecific antibodies enhance tumor‐infiltrating T cell cytotoxicity against autologous HER‐2‐expressing high‐grade ovarian tumors
por: Oberg, Hans‐Heinrich, et al.
Publicado: (2019)

Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors()
por: Bondarenko, Gennadiy, et al.
Publicado: (2015)

Enhancement of Tumor Radio‐response by Irinotecan in Human Lung Tumor Xenografts
por: Tamura, Kenji, et al.
Publicado: (1997)

High frequency of HLA class I antigen processing machinery (APM) component upregulation in primary hepatocellular carcinoma tumors
por: Grizzi, Fabio, et al.
Publicado: (2013)

Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors
por: Kim, Sanghyun P., et al.
Publicado: (2022)

Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV- induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice [published erratum appears in J Exp Med 1996 Sep 1;184(3):1199]
Publicado: (1996)

Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras
Publicado: (1994)

Focused ultrasound: an effective technique for unleashing the power of immunotherapy in the tumor microenvironment?
por: Repasky, Elizabeth
Publicado: (2015)

Sequential Systemic Administrations of Combretastatin A4 Phosphate and Radioiodinated Hypericin Exert Synergistic Targeted Theranostic Effects with Prolonged Survival on SCID Mice Carrying Bifocal Tumor Xenografts
por: Li, Junjie, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8rqgjl4skhg6tq4m5gl4nga2e4